Literature DB >> 20872564

Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects.

Soudabeh Fallah1, Morteza Seifi, Asghar Ghasemi, Mohsen Firoozrai, Ali Samadikuchaksaraei.   

Abstract

PURPOSE: To investigate the association of matrix metalloproteinase-9 (MMP-9) and paraoxonase 1 (PON1) 192 polymorphisms with susceptibility to coronary artery stenosis (CAS) and the number of diseased vessels in patients with CAS.
METHODS: The study population comprised 302 unrelated Iranian individuals, including 145 patients with CAS and 157 control subjects. Genotypes for MMP-9 and PON1 192 polymorphisms were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
RESULTS: In our study, distributions of the TT genotype of MMP-9 and the RR genotype of PON1 192 were significantly higher in patients compared with healthy control subjects (P<0.05). Subsequent analysis demonstrated that a significant difference existed in the male (TT+TC vs. CC and RR+QR vs. QQ, P<0.01) but not in the female. The associations of these polymorphisms with the severity of stenosis were also evaluated, which according to results distribution of MMP-9 and PON1 192 genotypes were not significantly different compared with the severity of stenosis (P>0.05).
CONCLUSIONS: The observation indicates that the polymorphisms in the MMP-9 and PON1 192 genes potentially play a role in the manifestation of coronary atherosclerosis but does not have any effect on the number of diseased vessels in Iran. J. Clin. Lab. Anal. 24:305-310, 2010.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872564      PMCID: PMC6647583          DOI: 10.1002/jcla.20406

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  37 in total

Review 1.  Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.

Authors:  Andrew C Newby
Journal:  Physiol Rev       Date:  2005-01       Impact factor: 37.312

2.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Authors:  A D Watson; J A Berliner; S Y Hama; B N La Du; K F Faull; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.

Authors:  Hyun-Jai Cho; In-Ho Chae; Kyung-Woo Park; Jae-Ran Ju; Seil Oh; Myoung-Mook Lee; Young-Bae Park
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

5.  Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.

Authors:  B Zhang; S Ye; S M Herrmann; P Eriksson; M de Maat; A Evans; D Arveiler; G Luc; F Cambien; A Hamsten; H Watkins; A M Henney
Journal:  Circulation       Date:  1999-04-13       Impact factor: 29.690

6.  A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.

Authors:  M C Vohl; T A Neville; R Kumarathasan; S Braschi; D L Sparks
Journal:  Biochemistry       Date:  1999-05-11       Impact factor: 3.162

7.  The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases.

Authors:  Olga Khersonsky; Dan S Tawfik
Journal:  J Biol Chem       Date:  2006-01-10       Impact factor: 5.157

8.  The molecular basis of the human serum paraoxonase activity polymorphism.

Authors:  R Humbert; D A Adler; C M Disteche; C Hassett; C J Omiecinski; C E Furlong
Journal:  Nat Genet       Date:  1993-01       Impact factor: 38.330

9.  Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.

Authors:  Elif Ozkök; Makbule Aydin; Erhan Babalik; Zeynep Ozbek; Nurhan Ince; Ihsan Kara
Journal:  Med Sci Monit       Date:  2008-10

10.  Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.

Authors:  Alireza Pasdar; Helen Ross-Adams; Alastair Cumming; John Cheung; Lawrence Whalley; David St Clair; Mary-Joan MacLeod
Journal:  BMC Med Genet       Date:  2006-03-21       Impact factor: 2.103

View more
  5 in total

1.  Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients.

Authors:  Mehmet Yavuz Gözükara; Abdurrezzak Börekçi; Mustafa Gür; Nurten Aksoy; Taner Şeker; Onur Kaypaklı; Hakan Uçar; Caner Türkoğlu; Mevlüt Koç; İlyas Makca; Selahattin Akyol; Şahbettin Selek; Murat Çaylı
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

2.  Association of MMP-9 gene polymorphisms with acute coronary syndrome in the Uygur population of China.

Authors:  Lei Wang; Yi-Tong Ma; Xiang Xie; Yi-Ning Yang; Zhen-Yan Fu; Fen Liu; Xiao-Mei Li; Bang-Dang Chen
Journal:  World J Emerg Med       Date:  2011

Review 3.  Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis.

Authors:  Xiao Wang; Lei-zhi Shi
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

4.  Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis.

Authors:  Ming-Ming Zhang; Xue-Wei Chang; Xue-Qin Hao; Hao Wang; Xiang Xie; Shou-Yan Zhang
Journal:  Oncotarget       Date:  2017-12-15

5.  The association between Matrix Metallo-proteinases-9 (MMP-9) gene family polymorphisms and risk of Coronary Artery Disease (CAD): a systematic review and meta-analysis.

Authors:  Reza Hassanzadeh-Makoui; Bahman Razi; Saeed Aslani; Danyal Imani; Seyedeh Samaneh Tabaee
Journal:  BMC Cardiovasc Disord       Date:  2020-05-19       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.